Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $1.70 billion. The enterprise value is $1.38 billion.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 133.18 million shares outstanding. The number of shares has increased by 26.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 133.18M |
| Shares Change (YoY) | +26.02% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 0.69% |
| Owned by Institutions (%) | 59.13% |
| Float | 85.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 105.33 |
| Forward PS | n/a |
| PB Ratio | 4.43 |
| P/TBV Ratio | 4.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 92.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.75 |
Financial Efficiency
Return on equity (ROE) is -74.44% and return on invested capital (ROIC) is -30.71%.
| Return on Equity (ROE) | -74.44% |
| Return on Assets (ROA) | -28.58% |
| Return on Invested Capital (ROIC) | -30.71% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $194,805 |
| Profits Per Employee | -$2.91M |
| Employee Count | 77 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $3.76 million in taxes.
| Income Tax | 3.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.96% in the last 52 weeks. The beta is 1.54, so CNTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +54.96% |
| 50-Day Moving Average | 13.30 |
| 200-Day Moving Average | 15.26 |
| Relative Strength Index (RSI) | 49.11 |
| Average Volume (20 Days) | 664,293 |
Short Selling Information
| Short Interest | 5.33M |
| Short Previous Month | 5.20M |
| Short % of Shares Out | 4.70% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.51 |
Income Statement
In the last 12 months, CNTA had revenue of $15.00 million and -$223.85 million in losses. Loss per share was -$1.82.
| Revenue | 15.00M |
| Gross Profit | 15.00M |
| Operating Income | -195.74M |
| Pretax Income | -163.67M |
| Net Income | -223.85M |
| EBITDA | -195.40M |
| EBIT | -195.74M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $424.90 million in cash and $109.25 million in debt, giving a net cash position of $315.65 million or $2.37 per share.
| Cash & Cash Equivalents | 424.90M |
| Total Debt | 109.25M |
| Net Cash | 315.65M |
| Net Cash Per Share | $2.37 |
| Equity (Book Value) | 386.25M |
| Book Value Per Share | 2.90 |
| Working Capital | 424.90M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,304.95% |
| Pretax Margin | -1,467.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |